Good news for the sector came January 23 when global pharmaceutical giant AstraZeneca plc announced an eye-popping $820 ...

AdvanCell has secured $112 million in a Sanofi Ventures-backed series C funding round as the Australian radiopharma company ...

Gresham House Ventures commits €4.25m to Mobility Mojo, a dublin-based accessibility audit and data platform, to boost ...

AdvanCell announced the successful completion of an oversubscribed $112 million (US) Series C financing, making it the only ...

AdvanCell, an Australia-based radiopharmaceutical company, has raised $112m as investor interest in the radiopharma sector ...

Dublin-based accessibility start-up Mobility Mojo will receive €4.25m in investment from UK-based equity investor Gresham ...

Two months after launching Pep2Tango Therapeutics, VC firm Versant Ventures is unveiling another obesity-focused biotech in ...

London-based Gresham House Ventures, a growth equity investor, announced that it has committed a €4.25M investment in Mobility Mojo.

Helicore, which is developing a GIP-blocking antibody, is the fourth obesity drug developer to receive funding from Versant ...

The soaring demand for antidiabetic and weight-loss drugs has lured in many biotech and big Pharma companies. Onto this ...

By capitalizing on its advantages for business of all sizes, Wisconsin is seeing significant growth in legacy and emerging ...

Now, AH and Eli Lilly are rewriting the playbook with a ... Corporations prioritize consistent and growing cash flow and avoid high risk ventures. In contrast, VCs bet on future valuations and ...